Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.26M | -1.29M | -1.30M | -1.32M | -1.23M |
| Total Depreciation and Amortization | 93.10K | 91.20K | 89.60K | 91.60K | 93.60K |
| Total Amortization of Deferred Charges | 153.80K | 134.10K | 131.90K | 124.70K | 116.80K |
| Total Other Non-Cash Items | 1.20M | 243.60K | 235.60K | 205.40K | 166.60K |
| Change in Net Operating Assets | 162.90K | 392.80K | 408.90K | 358.90K | 222.40K |
| Cash from Operations | -657.70K | -423.90K | -431.90K | -535.20K | -628.40K |
| Capital Expenditure | -26.10K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | 83.60K | 83.60K | 83.60K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 41.30K | 41.30K | 33.00K | 32.50K | 23.70K |
| Cash from Investing | 15.20K | 41.30K | 116.60K | 116.10K | 107.30K |
| Total Debt Issued | 1.24M | 971.90K | 832.00K | 930.60K | 1.01M |
| Total Debt Repaid | -584.00K | -552.70K | -516.60K | -511.40K | -491.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 656.40K | 419.10K | 315.30K | 419.10K | 521.20K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13.80K | 36.40K | -- | -- | -- |